BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND SEPT6, RP5-876A24_2, 23157, ENSG00000125354, Q14141, SEP2, MGC16619, KIAA0128, MGC20339 AND Diagnosis
8348 results:

  • 1. Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced prostate cancer From Latin America: Challenges and Future Approaches.
    Manneh R; Verson CA; Martin A; Delgado A; Isaacsson Velho PH; Manduley A; Tejado L; Rodríguez Y; Vargas C; Barata PC
    JCO Precis Oncol; 2024 May; 8():e2300628. PubMed ID: 38748947
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat-ectomy. A nationwide population-based study.
    Scilipoti P; Liedberg F; Garmo H; Wilberg Orrason A; Stattin P; Westerberg M
    Scand J Urol; 2024 May; 59():98-103. PubMed ID: 38738332
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A cross-sectional study of ERG expression and the relationship with clinicopathological features of prostate cancer in Southwestern Uganda.
    Mitala Y; Ssenkumba B; Birungi A; Kiconco R; Mutakooha MM; Atwine R
    Diagn Pathol; 2024 May; 19(1):67. PubMed ID: 38730435
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Toward confident prostate cancer detection using ultrasound: a multi-center study.
    Wilson PFR; Harmanani M; To MNN; Gilany M; Jamzad A; Fooladgar F; Wodlinger B; Abolmaesumi P; Mousavi P
    Int J Comput Assist Radiol Surg; 2024 May; 19(5):841-849. PubMed ID: 38704793
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence.
    Liu C; Chang Z; Chen K; Xue Q; Shu B; Wei Z; Zhou X; Guo L; Zhang Y; Pan Y; Cao Q; Liang H; Sun Q; Zhang X
    J Nanobiotechnology; 2024 May; 22(1):224. PubMed ID: 38702709
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy.
    Lokeshwar SD; Ali A; Weiss TR; Reynolds J; Shuch BM; Ferencz T; Kyriakides TC; Mehal WZ; Brito J; Renzulli J; Leapman MS
    BMC Urol; 2024 May; 24(1):102. PubMed ID: 38702664
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dual-mode fluorescence and colorimetric smartphone-based sensing platform with oxidation-induced self-assembled nanoflowers for sarcosine detection.
    Liu P; Sun Q; Gai Z; Yang F; Yang Y
    Anal Chim Acta; 2024 Jun; 1306():342586. PubMed ID: 38692787
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Oncological Outcomes in Men With Favorable Intermediate Risk prostate cancer Enrolled in Active Surveillance.
    Pepe P; Pepe L; Pennisi M; Fraggetta F
    In Vivo; 2024; 38(3):1300-1305. PubMed ID: 38688647
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values.
    Rogic I; Golubic AT; Zuvic M; Smitran T; Jukic N; Gamulin M; Kastelan Z; Huic D
    Nucl Med Rev Cent East Eur; 2024; 27(0):6-12. PubMed ID: 38680016
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Community-Based prostate cancer Screening and Education Program for Asian American Men in Medically Underserved Communities.
    Cho D; Gor B; Hwang H; Wang X; Hernandez M; Jones LA; Frost J; Roberson P; Pettaway CA
    Int J Environ Res Public Health; 2024 Mar; 21(4):. PubMed ID: 38673327
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
    Lee LJ; Han CJ; Saligan L; Wallen GR
    Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Developing a Novel Enzalutamide-Resistant prostate cancer Model via AR F877L Mutation in LNCaP Cells.
    Wang R; Ma S; Xu N; Gan Y; Li P; Zhang J; Zhang Z; Gu Q; Xiang J
    Curr Protoc; 2024 Apr; 4(4):e1033. PubMed ID: 38652202
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Skin Changes in Suspected Lyme Disease.
    Vržogić P; Perica A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
    Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
    [No Abstract]    [Full Text] [Related]  

  • 15. AAT resistance-related AC007405.2 and AL354989.1 as novel diagnostic and prognostic markers in prostate cancer.
    Deng Y; Zhang C; Yu H; Chen G; Peng X; Li Y; Feng Z; Shi W; Bai X; Gou X; Liu N
    Aging (Albany NY); 2024 Apr; 16(8):7249-7266. PubMed ID: 38643469
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized prostate cancer.
    Basourakos SP; An A; Davuluri M; Pinheiro LC; Al Awamlh BAH; Borregales LD; Luan D; Tamimi RM; Hu JC; Kensler KH
    Urol Pract; 2024 May; 11(3):538-546. PubMed ID: 38640417
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
    Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
    Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Clinical study of artificial intelligence-guided image fusion assisted transperineal prostate biopsy].
    Hu J; Zhao XD; Zhou YL; Dong N; Ma MF; Chen YH; Sheng ZC; Dong J; He CQ; Xu S
    Zhonghua Nan Ke Xue; 2023 Aug; 29(8):729-735. PubMed ID: 38619521
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. cancer risk and male Infertility: Unravelling predictive biomarkers and prognostic indicators.
    Tiwari P; Yadav A; Kaushik M; Dada R
    Clin Chim Acta; 2024 May; 558():119670. PubMed ID: 38614420
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Do beta-blockers reduce negative intrusive thoughts and anxiety in cancer survivors? - An emulated trial.
    Ehrencrona C; Li Y; Angenete E; Haglind E; Franzén S; Grimby-Ekman A; Bock D
    BMC Cancer; 2024 Apr; 24(1):447. PubMed ID: 38605350
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 418.